Hal Sternberg

Hal Sternberg, Ph.D., is Vice President of Research. Prior to joining AgeX, he was BioTime’s Vice President of Research for over 25 years and was one of the company’s co-founders. Before that, Dr. Sternberg held various positions at the University of California at Berkeley from 1982 to 1988, where he worked on Alzheimer’s Disease. Dr. Sternberg was instrumental in the development of the medical product Hextend, bringing it through regulatory approval as a blood plasma volume expander for treating blood loss. Dr. Sternberg received his M.S. in Chemistry (1979) and Ph.D. in Biochemistry (1982) from the University of Maryland.